30.06.2014 Views

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

CHAPTER 14 OPIOID ANALGESICS<br />

may achieve the desired effect, although in general the<br />

level of sedation produced by standard clinical doses is<br />

poor for most opioids when used as the sole agent. Apart<br />

from providing increased sedation when used in combination<br />

with a sedative or tranquilizer, opioids as part of<br />

a premedication protocol can act in a pre-emptive<br />

fashion, reducing both the intraoperative and postoperative<br />

analgesic requirements. Controlling surgical pain in<br />

animals before they fully recover from general anesthesia<br />

is easier and requires less total drug to be administered<br />

than waiting for the animals to show obvious signs of<br />

pain and then administering an analgesic.<br />

Opioids and anesthesia induction<br />

Another preoperative application for some of the full<br />

opioid agonists is as a component of the protocol for<br />

induction of anesthesia. Selected opioid agents have<br />

been used for anesthetic induction in a number of situations<br />

because of the marked cardiovascular stability<br />

they provide, aside from bradycardia. This technique is<br />

most often reserved for very ill and moribund animals,<br />

the very elderly or those with a pronounced degree of<br />

cardiovascular compromise. In such cases, higher doses<br />

of ultra-fast acting pure agonist µ-receptor opioids (fentanyl,<br />

alfentanil) may be administered as part of a<br />

coinduction (immediately prior to the induction agent).<br />

As a result, the dose of induction agent will be significantly<br />

reduced but other unwanted effects such as ventilatory<br />

depression are minimized or, where seen, can<br />

be quickly managed in the anesthetized patient with a<br />

controlled airway. It is also recommended that where<br />

possible, without stressing the patient, animals be preoxygenated<br />

via facemask or oxygen chamber, prior to<br />

induction of anesthesia.<br />

The onset of anesthesia during an opioid induction is<br />

much slower than that achieved with other intravenous<br />

agents such as thiopental and propofol. Delay in onset<br />

during induction relates to those factors that influence<br />

the transfer across the blood–brain barrier: lipid solubility,<br />

ionization and protein binding. Some opioids, fentanyl<br />

in particular, make animals hyperresponsive to<br />

sudden, loud sounds, which should therefore be avoided<br />

during induction.<br />

Intraoperative use of opioids<br />

Many studies have demonstrated a reduced requirement<br />

for inhalant anesthetic agents (reduction in the minimum<br />

alveolar concentration – MAC) in animals that have<br />

received opioid analgesics. This effect is dose dependent;<br />

however, even at extremely high dose rates the MAC<br />

reduction is still not 100%, which further indicates the<br />

inability of opioids to act as true anesthetic agents.<br />

Therefore opioid analgesics can be used to supplement<br />

the main anesthetic agent, whether it be infused or<br />

inhaled, and at the same time provide analgesia; this<br />

combination of drugs is often referred to as ‘balanced<br />

anesthesia’.<br />

There are two commonly used approaches to the<br />

delivery of intraoperative opioids: intermittent bolus<br />

and continuous infusion.<br />

Intermittent boluses<br />

All µ-agonists, with the exception of the ultra-short<br />

acting agent remifentanil, can be administered by intermittent<br />

intravenous bolus, the important difference<br />

between them being the dosing intervals, which need to<br />

be greater for the longer-acting drugs. If such administration<br />

is continued for a long surgical procedure, then<br />

the dosing interval will often need to be increased as the<br />

case progresses to avoid accumulation, which may only<br />

become apparent during recovery. Signs of accumulation<br />

observed during recovery include prolongation of<br />

recovery, in particular delayed extubation, respiratory<br />

depression and possibly excitatory behavior, including<br />

thrashing and vocalization, which can be difficult to<br />

distinguish from insufficient analgesia and an extreme<br />

response to pain.<br />

Continuous infusion<br />

Shorter-acting µ-agonists are well suited to this technique<br />

and more recently have been developed for this<br />

purpose. As well as acting as supplements to inhalational<br />

anesthesia, these drugs may also be used as part<br />

of a total intravenous anesthesia (TIVA) protocol in<br />

conjunction with a hypnotic agent such as propofol and<br />

muscle relaxants. In some instances, all three classes of<br />

drug may be administered as continuous infusions. By<br />

selection of the appropriate agents and infusion rates,<br />

this technique can provide precise control of anesthetic<br />

depth and hence reduce recovery times. Fentanyl has<br />

traditionally been the agent of choice for this indication<br />

in veterinary anesthetic practice. The cumulative nature<br />

of fentanyl when infused for more than 90 min and<br />

the introduction of remifentanil means that fentanyl<br />

is no longer the infusion opioid of choice in most<br />

circumstances.<br />

Extradural and intrathecal<br />

administration of opioids<br />

Other techniques for opioid administration perioperatively<br />

are extradural (epidural) and intrathecal (subarachnoid,<br />

spinal) placement of opioids alone or in<br />

combination with local anesthetic agents. These techniques<br />

can be used to supplement general anesthesia or<br />

heavy sedation and provide highly effective analgesia<br />

with MAC reduction of 30–60% and good cardiovascular<br />

stability. Patient and procedure selection are very<br />

important if these techniques are to be used without<br />

general anesthesia but they can be extremely successful<br />

316

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!